Q4 2024 Holdings
Filed 2025-02-14 | 31 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $162.9M | 3,874,182 | 11.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $133.0M | 1,625,000 | 9.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $126.9M | 1,621,600 | 9.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $107.4M | 2,740,000 | 7.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $94.6M | 4,205,000 | 6.9% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $82.8M | 1,958,600 | 6.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $68.5M | 1,525,000 | 5.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $66.1M | 2,300,000 | 4.8% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $56.5M | 3,000,000 | 4.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $53.7M | 6,881,629 | 3.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $46.3M | 1,988,084 | 3.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $46.0M | 2,400,000 | 3.4% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $41.1M | 950,000 | 3.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $37.2M | 2,218,425 | 2.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $36.6M | 1,911,433 | 2.7% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $30.0M | 4,308,425 | 2.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $27.5M | 1,419,714 | 2.0% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $23.4M | 5,384,616 | 1.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $19.3M | 5,925,000 | 1.4% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $18.3M | 800,000 | 1.3% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $18.0M | 500,000 | 1.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $16.1M | 2,000,000 | 1.2% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $13.1M | 290,000 | 1.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $9.4M | 1,284,110 | 0.7% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.6M | 750,000 | 0.6% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.3M | 500,000 | 0.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $5.2M | 400,000 | 0.4% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $4.6M | 1,575,000 | 0.3% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $3.6M | 483,000 | 0.3% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $2.4M | 237,704 | 0.2% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $876.1K | 351,848 | 0.1% |